Showing results (41-50 of 133) with videos related to
Sort By:
Pageof 14
The FEBS Journal|November 11, 2005
Chromosomal protein HMGN1 modulates the expression of N-cadherinYaffa R Rubinstein, Takashi Furusawa, Jae-Hwan Lim, et al.Cancer Research|February 4, 2016
Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing TherapiesHee-Sheung Lee, Nicholas C O Lee, Natalay Kouprina, et al.Leukemia & Lymphoma|October 1, 2016
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the bloodAmber Shatzer, Mir A Ali, Mayra Chavez, et al.Journal for Immunotherapy of Cancer|July 26, 2020
Clinical outcomes of prexasertib monotherapy in recurrent <i>BRCA</i> wild-type high-grade serous ovarian cancer involve innate and adaptive immune responsesErika J Lampert, Ashley Cimino-Mathews, Joo Sang Lee, et al.The Journal of Urology|November 20, 2015
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor CellsEric C Kauffman, Min-Jung Lee, Sylvia V Alarcon, et al.Annals of Clinical and Laboratory Science|October 29, 2005
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometryEun Joo Chung, Sunmin Lee, Edward A Sausville, et al.Cancer Research|October 15, 2013
The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor modelsNaoto Miyajima, Shinji Tsutsumi, Carole Sourbier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2019
Rebalancing Protein Homeostasis Enhances Tumor Antigen PresentationAlex M Jaeger, Lauren Stopfer, Sunmin Lee, et al.Journal of Thrombosis and Haemostasis : JTH|February 6, 2020
Pharmacologic dissection of the overlapping impact of heat shock protein family members on platelet functionJoseph W Jackson, Genesis M Rivera-Marquez, Kristin Beebe, et al.Oncotarget|August 6, 2016
EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse modelsAbhilash Venugopalan, Min-Jung Lee, Gang Niu, et al.Pageof 14